Advisornet Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-507
Closed -$30K – 1882
2021
Q1
$30K Sell
507
-795
-61% -$43.2K ﹤0.01% 1082
2020
Q4
$65K Hold
1,302
– – 0.01% 803
2020
Q3
$66K Hold
1,302
– – 0.01% 787
2020
Q2
$46K Hold
1,302
– – ﹤0.01% 885
2020
Q1
$33K Hold
1,302
– – ﹤0.01% 932
2019
Q4
$36K Sell
1,302
-1,000
-43% -$23.9K ﹤0.01% 1005
2019
Q3
$62K Hold
2,302
– – 0.01% 824
2019
Q2
$94K Buy
2,302
+1,302
+130% +$36.6K 0.01% 632
2019
Q1
$24K Buy
+1,000
New +$18.1K ﹤0.01% 955

Other funds holding AXNX

Advisornet Financial's AXNX Position: Q2 2021 in Review

Advisornet Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2021, closing a stake of 507 shares — an estimated $30K sold.

Advisornet Financial first reported a position in AXNX in Q1 2019 and held it in 9 quarters. The position peaked at $94K in Q2 2019. 177 funds tracked by Wall St. Rank hold AXNX as of Q2 2021.

  • Advisornet Financial reported no remaining Axonics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Advisornet Financial sold 507 Axonics, Inc. Common Stock shares in Q2 2021, an estimated $30K.
  • Advisornet Financial first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Advisornet Financial's Axonics, Inc. Common Stock position peaked at $94K in Q2 2019.
  • 177 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2021.

Based on Advisornet Financial's 13F filing for Q2 2021, filed 6 Jul 2021.